Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Desvenlafaxine Treatment Report
What is Desvenlafaxine?

Desvenlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI). It is an extended release formulation believed to treat depression by affecting the levels of serotonin and norepinephrine, two neurotransmitters associated with depression.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Depression 7 1

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
1 100%

Dosages

  1 mg daily 50 mg daily 100 mg daily
  1 Number of Patients: 1 4 Number of Patients: 4 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Desvenlafaxine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Expense
1 100% Expense: 100%

See all 1 patient who’ve stopped taking Desvenlafaxine

Duration See details about how long patients take this treatment ▼

Currently Taking Desvenlafaxine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
1
2
0

Stopped Taking Desvenlafaxine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
1 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%

Report created on November 23, 2009.